![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » PerkinElmer Acquires Vanadis Diagnostics
PerkinElmer Acquires Vanadis Diagnostics
![correct_handshake.gif](https://www.fdanews.com/ext/resources/test/Device_Images/handshake.gif?t=1576815772&width=430)
PerkinElmer has acquired Vanadis Diagnostics, a Swedish company that is developing a novel solution for noninvasive prenatal testing based on digital analysis of cell-free DNA.
Terms were not disclosed.
The deal is anticipated to build upon PerkinElmer’s maternal fetal health offerings, which provide customers a portfolio of traditional serum screening solutions, the company says.
“The Vanadis platform will enable PerkinElmer to offer a simplified, cost-effective, high-throughput approach to NIPT to help facilitate wider access for pregnant women,” PerkinElmer says. — Jonathon Shacat
Upcoming Events
-
21Oct